Clinical trialNCT07650916RecruitingPhase 3Interventional

A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

SponsorViiV HealthcareEnrollment564HIV Infections

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study compares the efficacy, safety and tolerability of CAB ULA and RPV ULA administered with CAB long acting (LA) and RPV LA administered in adults and adolescents with HIV who are virologically suppressed on anti-retroviral therapy (ART).

clinicaltrials.gov ↗

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

88 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Gsk Investigational Site
Buenos Aires, Argentina
Pedro Cahn
Recruiting
Gsk Investigational Site
Buenos Aires, Argentina
Veronica Lacal Ridilenir
Recruiting
Gsk Investigational Site
Buenos Aires, Argentina
Sebastian Nunez
Recruiting
Gsk Investigational Site
Ciudad Autonoma Buenos Aires, Argentina
Ezequiel Cordova
Recruiting
Gsk Investigational Site
Ciudad Autonoma Buenos Aires, Argentina
Gustavo Lopardo
Recruiting
Gsk Investigational Site
Córdoba, Argentina
Marcelo Martins
Recruiting
Gsk Investigational Site
Rosario, Argentina
Sergio Lupo
Recruiting
Gsk Investigational Site
San Miguel de Tucumán, Argentina
Juan Gonzalo Tomas
Recruiting

Australia

Gsk Investigational Site
Darlinghurst, New South Wales, Australia
Mark O'Reilly
Recruiting
Gsk Investigational Site
Sydney, New South Wales, Australia
Mark Bloch
Recruiting
Gsk Investigational Site
Taringa, Queensland, Australia
Fiona Bisshop
Recruiting

Canada

Gsk Investigational Site
Vancouver, British Columbia, Canada
Malcolm Hedgcock
Recruiting
Gsk Investigational Site
Toronto, Ontario, Canada
Mona Loutfy
Recruiting
Gsk Investigational Site
Montreal, Quebec, Canada
Jason Szabo
Recruiting
Gsk Investigational Site
Montreal, Quebec, Canada
Elise Sasseville
Recruiting

Japan

Gsk Investigational Site
Aichi, Japan
Yoshiyuki Yokomaku
Recruiting
Gsk Investigational Site
Kanagawa, Japan
Yukihiro Yoshimura
Recruiting
Gsk Investigational Site
Osaka, Japan
Dai Watanabe
Recruiting
Gsk Investigational Site
Tokyo, Japan
Eisuke Adachi
Recruiting
Gsk Investigational Site
Tokyo, Japan
Ryoko Sekiya
Recruiting
Gsk Investigational Site
Tokyo, Japan
Hiroyuki Gatanaga
Recruiting

Mexico

Gsk Investigational Site
San Pedro Garza García, Nuevo León, Mexico
Reynaldo Lara-Medrano
Recruiting
Gsk Investigational Site
Guadajalara, Mexico
Luz Alicia Gonzalez-Hernandez
Recruiting
Gsk Investigational Site
Mexico City, Mexico
Alvaro Lopez Iñiguez
Recruiting
Gsk Investigational Site
Mexico City, Mexico
Edgar Perez-Barragan
Recruiting
Gsk Investigational Site
Mérida, Mexico
Orlando Paredes Ceballos
Recruiting

Puerto Rico

Gsk Investigational Site
San Juan, Puerto Rico
Javier Morales-Ramirez
Recruiting

Spain

Gsk Investigational Site
Alicante, Spain
Sergio Reus Bañuls
Recruiting
Gsk Investigational Site
Badalona, Spain
Anna Bonjoch Badia
Recruiting
Gsk Investigational Site
Barcelona, Spain
Paula Prieto
Recruiting
Gsk Investigational Site
Barcelona, Spain
Joaquin Burgos Cibrian
Recruiting
Gsk Investigational Site
Barcelona, Spain
Josep Mallolas Masferrer
Recruiting
Gsk Investigational Site
Barcelona, Spain
Arkaitz Imaz Vacas
Recruiting
Gsk Investigational Site
Burgos, Spain
Luis Buzon
Recruiting
Gsk Investigational Site
Cartagena Murcia, Spain
Francisco Jesús Vera Méndez
Recruiting
Gsk Investigational Site
Córdoba, Spain
Ignacio Pérez Valero
Recruiting
Gsk Investigational Site
Elche Alicante, Spain
MAR MASIA
Recruiting
Gsk Investigational Site
Madrid, Spain
Cristina Diez Romero
Recruiting
Gsk Investigational Site
Madrid, Spain
Guillermo Cuevas Tascon
Recruiting
Gsk Investigational Site
Madrid, Spain
Sergio Serrano Villar
Recruiting

48 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

CAB LACAB ULARPV LARPV ULA

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 25 Jun 2026
Primary completion: 4 Sept 2029
Completion: 4 Sept 2029
Last update posted: 14 Aug 2026
Registered enrollment: 564
Registry id: NCT07650916

Cross-registrations

EU-CTR / CTIS (EudraCT)2024-518511-19-00

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.